Harvard Bioscience (HBIO) ROIC: History & Chart

Name: Harvard Bioscience, Inc. (HBIO) Return on Invested Capital (ROIC) — historical time series
Creator: TGMCharts

Compare

Harvard Bioscience, Inc.(HBIO)

Medical - Instruments & Supplies · Holliston, MA

$8.67+0.17 (+2.00%)

Delayed quote: Oct 6, 2026, 11:35 AM EDT

Compare

About Harvard Bioscience, Inc.

Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services for life science applications in the Americas, Europe, the Middle East, Africa, Asia, and internationally. The company offers cellular and molecular technology products, such as syringe and peristaltic infusion pump products; electroporation and electrofusion instruments, amino acid analyzers, spectrophotometers, and other equipment for molecular level testing and research; and precision scientific measuring instrumentation and equipment, including data acquisition systems for cellular analysis, complete micro electrode array solutions for in vivo recordings, and in vitro systems for extracellular recordings. It provides preclinical products that includes platform to assess physiological data from organisms for research, drug discovery, and drug development services comprising implantable and externally worn telemetry systems for use in research to collect cardiovascular, central nervous system, respiratory, and metabolic data; behavioral products; isolated organ and surgical products, instruments and accessories for tissue, and organ-based lab research, including surgical products, infusion systems, and behavior research systems; turn-key respiratory system solutions, including plethysmograph chambers, data acquisition hardware, physiological signal analysis software, and final report generation; inhalation and exposure systems; and GLP-capable data acquisition and analysis systems. The company markets its products through websites and distributors to research scientists in pharmaceutical and biotechnology companies, universities, hospitals, and government laboratories; and contract research organizations and academic laboratories. It primarily sells its products under the Harvard Apparatus, Biochrom, BTX, HEKA, KD Scientific, MCS, Warner, DSI, Panlab, Hugo Sachs, and Buxco brands. Harvard Bioscience, Inc. was founded in 1901 and is based in Holliston, Massachusetts.

Holliston, MA

328 employees

www.harvardbioscience.com

Healthcare / Medical - Instruments & Supplies

Sector: Healthcare
Industry: Medical - Instruments & Supplies
CEO: John D. Duke

View full financials

HBIO Return on Invested Capital (ROIC) Metrics

RETURN ON INVESTED CAPITAL (ROIC)

1.99%

RETURN ON INVESTED CAPITAL (ROIC) AVG TTM

-49.95%

RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y

-27.31%

RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y

-1.05%

RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y

-0.84%

RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y

0.06%

RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y

2.37%

CURRENT VS TTM AVG

+103.99%

CURRENT VS 3Y AVG

+107.30%

CURRENT VS 5Y AVG

+289.69%

CURRENT VS 10Y AVG

+337.72%

CURRENT VS 15Y AVG

+3024.45%

CURRENT VS 20Y AVG

-15.97%

SECTOR MEDIAN · HEALTHCARE

-33.50%

median of 671 covered companies

CURRENT VS SECTOR MEDIAN

+105.95%

vs the sector median at left

NAME	MARKET CAP	RETURN ON INVESTED CAPITAL (ROIC)	TTM	3Y	5Y
Harvard Bioscience, Inc. (HBIO)	$39.10M	1.99%	-49.95%	-27.31%	-1.05%
Incannex Healthcare Limited (IXHL)vs ›	$38.35M	-32.18%	-103.25%	-133.41%	-116.42%
Nephros, Inc. (NEPH)vs ›	$39.90M	12.67%	5.06%	-12.78%	-16.11%
Metagenomi, Inc. Common Stock (MGX)vs ›	$39.92M	-66.03%	-39.70%	-29.53%	-27.72%
Edesa Biotech, Inc. (EDSA)vs ›	$37.28M	-166.02%	-208.81%	-185.70%	-165.34%
Elicio Therapeutics, Inc. (ELTX)vs ›	$36.80M	-171.36%	-234.34%	-204.54%	-189.00%
Filana Therapeutics, Inc. (FLNA)vs ›	$41.78M	-72.12%	-128.00%	-128.00%	-128.00%
Precipio, Inc. (PRPO)vs ›	$41.92M	-8.43%	-19.61%	-40.73%	-42.38%
Elutia Inc (ELUT)vs ›	$35.54M	-79.27%	-43.87%	-333.47%	-212.56%
QT Imaging Holdings, Inc. (QTI)vs ›	$35.80M	-22.79%	-490.24%	-256.92%	-224.31%

NAME

MARKET CAP

RETURN ON INVESTED CAPITAL (ROIC)

TTM

Harvard Bioscience, Inc. (HBIO)

$39.10M

1.99%

-49.95%

-27.31%

-1.05%

Incannex Healthcare Limited (IXHL)vs ›

$38.35M

-32.18%

-103.25%

-133.41%

-116.42%

Nephros, Inc. (NEPH)vs ›

$39.90M

12.67%

5.06%

-12.78%

-16.11%

Metagenomi, Inc. Common Stock (MGX)vs ›

$39.92M

-66.03%

-39.70%

-29.53%

-27.72%

Edesa Biotech, Inc. (EDSA)vs ›

$37.28M

-166.02%

-208.81%

-185.70%

-165.34%

Elicio Therapeutics, Inc. (ELTX)vs ›

$36.80M

-171.36%

-234.34%

-204.54%

-189.00%

Filana Therapeutics, Inc. (FLNA)vs ›

$41.78M

-72.12%

-128.00%

Precipio, Inc. (PRPO)vs ›

$41.92M

-8.43%

-19.61%

-40.73%

-42.38%

Elutia Inc (ELUT)vs ›

$35.54M

-79.27%

-43.87%

-333.47%

-212.56%

QT Imaging Holdings, Inc. (QTI)vs ›

$35.80M

-22.79%

-490.24%

-256.92%

-224.31%

Return on Invested Capital (ROIC) Formula & Definition

ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)

Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.

Return on Invested Capital (ROIC) FAQ

What is the return on invested capital (ROIC) for Harvard Bioscience, Inc. (HBIO)?

The return on invested capital (ROIC) for HBIO stock is 1.99%.

Is Harvard Bioscience, Inc.'s return on invested capital (ROIC) high or low?

The return on invested capital (ROIC) of 1.99% is 290% above its 5-year average of -1.05%, near the high end of its 5-year range (-89.10%–2.35%).

What is the TTM average return on invested capital (ROIC) for Harvard Bioscience, Inc. (HBIO)?

The TTM average return on invested capital (ROIC) for HBIO stock is -49.95%.

What is the 3Y average return on invested capital (ROIC) for Harvard Bioscience, Inc. (HBIO)?

The 3Y average return on invested capital (ROIC) for HBIO stock is -27.31%.

What is the 5Y average return on invested capital (ROIC) for Harvard Bioscience, Inc. (HBIO)?

The 5Y average return on invested capital (ROIC) for HBIO stock is -1.05%.

What is the 10Y average return on invested capital (ROIC) for Harvard Bioscience, Inc. (HBIO)?

The 10Y average return on invested capital (ROIC) for HBIO stock is -0.84%.

What is the 15Y average return on invested capital (ROIC) for Harvard Bioscience, Inc. (HBIO)?

The 15Y average return on invested capital (ROIC) for HBIO stock is 0.06%.

What is the 20Y average return on invested capital (ROIC) for Harvard Bioscience, Inc. (HBIO)?

The 20Y average return on invested capital (ROIC) for HBIO stock is 2.37%.

DATE	RETURN ON INVESTED CAPITAL (ROIC)
2026-06-30	1.99%
2026-03-31	2.13%
2025-12-31	-81.10%
2025-09-30	-85.15%
2025-06-30	-87.61%
2025-03-31	-89.10%
2024-12-31	-5.72%
2024-09-30	-5.30%
2024-06-30	-4.54%
2024-03-31	-1.92%
2023-12-31	1.62%
2023-09-30	0.97%
2023-06-30	-1.36%
2023-03-31	1.22%
2022-12-31	-5.51%
2022-09-30	-3.72%
2022-06-30	-0.35%
2022-03-31	-3.30%
2021-12-31	1.47%
2021-09-30	2.35%
2021-06-30	2.07%
2021-03-31	2.46%
2020-12-31	0.16%
2020-09-30	-0.69%
2020-06-30	-1.87%
2020-03-31	-2.05%
2019-12-31	0.36%
2019-09-30	0.44%
2019-06-30	1.93%
2019-03-31	1.51%
2018-12-31	0.66%
2018-09-30	-0.06%
2018-06-30	-0.77%
2018-03-31	-0.49%
2017-12-31	-0.10%
2017-09-30	-1.91%
2017-06-30	-2.62%
2017-03-31	-3.55%
2016-12-31	-3.14%
2016-09-30	-1.76%
2016-06-30	-1.70%
2016-03-31	-0.75%
2015-12-31	-1.66%
2015-09-30	0.24%
2015-06-30	2.04%
2015-03-31	1.90%
2014-12-31	2.96%
2014-09-30	4.41%
2014-06-30	3.05%
2014-03-31	2.17%
2013-12-31	1.23%
2013-09-30	-0.92%
2013-06-30	-0.21%
2013-03-31	1.15%
2012-12-31	1.76%
2012-09-30	2.29%
2012-06-30	2.57%
2012-03-31	3.18%
2011-12-31	4.36%
2011-09-30	4.82%
2011-06-30	7.87%
2011-03-31	7.88%
2010-12-31	9.00%
2010-09-30	7.98%
2010-06-30	8.17%
2010-03-31	6.83%
2009-12-31	6.17%
2009-09-30	7.73%
2009-06-30	8.52%
2009-03-31	9.48%
2008-12-31	8.40%
2008-09-30	7.72%
2008-06-30	7.33%
2008-03-31	8.45%
2007-12-31	8.94%
2007-09-30	8.77%
2007-06-30	9.26%
2007-03-31	8.81%
2006-12-31	8.72%
2006-09-30	11.45%
2006-06-30	11.71%
2006-03-31	-19.97%
2005-12-31	-22.49%
2005-09-30	-20.33%
2005-06-30	-20.95%
2005-03-31	2.35%
2004-12-31	2.17%
2004-09-30	2.66%
2004-06-30	2.50%
2004-03-31	3.25%
2003-12-31	3.98%
2003-09-30	2.14%
2003-06-30	1.27%

DATE

RETURN ON INVESTED CAPITAL (ROIC)

2026-06-30

1.99%

2026-03-31

2.13%

2025-12-31

-81.10%

2025-09-30

-85.15%

2025-06-30

-87.61%

2025-03-31

-89.10%

2024-12-31

-5.72%

2024-09-30

-5.30%

2024-06-30

-4.54%

2024-03-31

-1.92%

2023-12-31

1.62%

2023-09-30

0.97%

2023-06-30

-1.36%

2023-03-31

1.22%

2022-12-31

-5.51%

2022-09-30

-3.72%

2022-06-30

-0.35%

2022-03-31

-3.30%

2021-12-31

1.47%

2021-09-30

2.35%

2021-06-30

2.07%

2021-03-31

2.46%

2020-12-31

0.16%

2020-09-30

-0.69%

2020-06-30

-1.87%

2020-03-31

-2.05%

2019-12-31

0.36%

2019-09-30

0.44%

2019-06-30

1.93%

2019-03-31

1.51%

2018-12-31

0.66%

2018-09-30

-0.06%

2018-06-30

-0.77%

2018-03-31

-0.49%

2017-12-31

-0.10%

2017-09-30

-1.91%

2017-06-30

-2.62%

2017-03-31

-3.55%

2016-12-31

-3.14%

2016-09-30

-1.76%

2016-06-30

-1.70%

2016-03-31

-0.75%

2015-12-31

-1.66%

2015-09-30

0.24%

2015-06-30

2.04%

2015-03-31

1.90%

2014-12-31

2.96%

2014-09-30

4.41%

2014-06-30

3.05%

2014-03-31

2.17%

2013-12-31

1.23%

2013-09-30

-0.92%

2013-06-30

-0.21%

2013-03-31

1.15%

2012-12-31

1.76%

2012-09-30

2.29%

2012-06-30

2.57%

2012-03-31

3.18%

2011-12-31

4.36%

2011-09-30

4.82%

2011-06-30

7.87%

2011-03-31

7.88%

2010-12-31

9.00%

2010-09-30

7.98%

2010-06-30

8.17%

2010-03-31

6.83%

2009-12-31

6.17%

2009-09-30

7.73%

2009-06-30

8.52%

2009-03-31

9.48%

2008-12-31

8.40%

2008-09-30

7.72%

2008-06-30

7.33%

2008-03-31

8.45%

2007-12-31

8.94%

2007-09-30

8.77%

2007-06-30

9.26%

2007-03-31

8.81%

2006-12-31

8.72%

2006-09-30

11.45%

2006-06-30

11.71%

2006-03-31

-19.97%

2005-12-31

-22.49%

2005-09-30

-20.33%

2005-06-30

-20.95%

2005-03-31

2.35%

2004-12-31

2.17%

2004-09-30

2.66%

2004-06-30

2.50%

2004-03-31

3.25%

2003-12-31

3.98%

2003-09-30

2.14%

2003-06-30

1.27%

Return on Invested Capital (ROIC): 1.99%

HBIO Return on Invested Capital (ROIC)

HBIO Average Return on Invested Capital (ROIC) Chart

HBIO Current vs Average Return on Invested Capital (ROIC) Chart

HBIO Return on Invested Capital (ROIC) Metrics

HBIO Competitors' Return on Invested Capital (ROIC)

Capital Efficiency

Return on Invested Capital (ROIC) Formula & Definition

Return on Invested Capital (ROIC) FAQ

HBIO Return on Invested Capital (ROIC) History

Related Metrics